Citius Pharmaceuticals, Inc. (CTXR) vs Passage Bio, Inc. (PASG)
Citius Pharmaceuticals, Inc. and Passage Bio, Inc. are both Biotechnology companies. Citius Pharmaceuticals, Inc. and Passage Bio, Inc. are of similar size ($15.7M and $15.5M). Across the 10 metrics below, Citius Pharmaceuticals, Inc. leads on 6 and Passage Bio, Inc. on 4.
Valuation
Profitability
| Metric | CTXR | PASG | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (64.51%) | (169.09%) | (57.72%) |
| Return on assets | (34.29%) | (69.20%) | (49.22%) |
| Return on invested capital | (58.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack